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Introduction
Primary liver cancer is hepatocellular carcino-
ma, which can be developed under the influence 
of various etiological agents that cause altera-
tions of hepatocites that gain the characteris-
tics of malignant cells. Primary liver cancer is 
one of the most common cancers worldwide and 
in some countries it is the leading form of a ma-
lignant disease. At least one million new cases 
of liver cancer are identified annually, with high 
mortality rate despite the use of therapy (Rust-
gi, 1987; Munoz, Bosch, 1988; Simonetti, et al., 
1991; Leong, 1999). This hepatocellular carci-
noma causes between 250,000 and one million 
deaths annually worldwide (Bosch, Munoz, 1991). 
 Liver cancer is a rare disease in Western coun-
tries compared with high rates in South Africa 
and Southeast Asia. So, populations with high-risk 
are those from developing countries and in these 
countries the main risk factors for primary liv-
er cancer are: hepatitis B virus and aflatoxin con-
tamination. In contrast, the developed countries 
have hepatitis C and alcohol consumption as the 
main risk factors (McGlynn, et al., 2001). Among 
the main risk factors for liver carcinogenesis are 
also cirrhosis, constant irritation of hepatocytes 
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with chemicals, chronic infections of the diges-
tive tract and malnutrition. 
Geographic and ethnic variation  
of liver cancer
Liver cancer has unequal distribution in the world. 
Thus, in tropical Africa and Asian countries like 
Taiwan, Singapore, Korea and China was recorded 
the highest incidence - 20 to even 150 in a popula-
tion of 100,000 (Oon, et al., 1989). The lowest in-
cidence of only 1 to 3 were found in South Ameri-
ca, Australia, India and Northern countries, while 
the average values occurred in Japan, Middle East 
and Mediterranean countries (Munoz, Linsell, 
1982; Lua, Lai, 1990). 
Over time it was observed that the incidence of 
liver cancer in migrants becomes equal to those 
present in local populations. Thus, for example, In-
dians who have settled in Hong Kong and Singa-
pore have incidence close to the native population 
of these cities, and almost two times higher than 
their countrymen. Furthermore, a gradual decline 
of the incidence has been noted in Japanese and 
Korean immigrants who moved to California and 
Hawaii. Also, Jewish people born in Africa or Asia 
had higher incidence of liver cancer compared with 
those who were born in Europe, America or Isra-
el (Parkin, et al., 1992). The difference in incidence 
rates among migrants of the same ethnic group liv-
ing in different areas suggests that environmental 
factors, rather than ethnic background, may play a 
major role in the determination of the disease.
 The differences in incidence rate can be ob-
served in the border of a country like China. The 
main endemic areas for HCC were along the 
south-east coast where mortality rate exceeds 60 
per 100,000 people per year, in contrast to the rest 
of the country with a much lower incidence, be-
low 6. This is due to the fact that these critical ar-
eas are supplied with stagnant and contaminated 
water (Chen, et al., 1997). 
 This geographic distribution of diseases points 
to a complex interactions between multiple etio-
logical, locally conditioned factors around the 
Planet, which cause uneven distribution of this 
malignancy. Environmental agents, in particu-
lar the prevalence of chronic HBV and HCV infec-
tions, are closely related with the appearance of 
this cancer (Leong, Leong, 2005).
Gender and age variation
Liver cancer is four to eight times more common 
in males than females. The gender difference may 
be due to discrepancies in the hepatitis B surface 
antigen (HBsAg) carrier rate, with higher inci-
dence of liver cirrhosis in men, lifestyle (increased 
alcohol intake and smoking), occupational expo-
sure and hormone status between males and fe-
males (sex hormones, in combination with oth-
er factors, can act as tumor promoters) (Leong, 
Leong, 2005).
In high-risk countries (in Africa and Asia), liver 
cancer can arise before the age of 20, whereas, in 
countries at low risk (Western countries), liver can-
cer is rare before the age of 50 (Bosch, et al., 2004). 
Chronic liver diseases
Liver cirrhosis 
Liver cancer is mostly associated with cirrhosis, 
a chronic, irreversible damage to the liver paren-
chyma. Both diseases can have the same or similar 
causes and it is believed that in most countries in 
80-90% of cases cirrhosis develops into liver can-
cer (Shikata, 1987).
Hepatitis B 
Hepatitis B is a contagious disease of the liver 
caused by HBV. Acute or chronic, infection can 
lead to liver damage and even HCC. It is esti-
mated that two billion people worldwide are in-
fected with HBV and about 350 million of them 
develop chronic infection. Prevalence of HBV car-
riers varies from a low 0.1% to 2% in regions such 
as USA, Canada, Western Europe, Australia and 
New Zealand, through the intermediary 3% to 
5% in the Mediterranean, Japan, Central Asia and 
Latin America, to the high 10% to 20% recorded in 
China and sub-Saharan Africa (Alter, et al., 1990). 
In Vojvodina, during the nineties, the incidence 
of hepatitis B was in the range of 5.7 per 100,000 
(1997) to 3.9 per 100,000 (1999). It is estimated that 
80% of liver cancer cases worldwide are associat-
ed with this viral infection (Šeguljev, et al., 2003). 
Hepatitis C 
Hepatitis C is a contagious disease of the liver 
caused by HCV which was until 1989 classified 
as the “non A, non B hepatitis”. Infection may be 
acute but after a few months disease can go into a 
chronic stage which can result in cirrhosis and liv-
er cancer. Its relationship with liver cancer is con-
sidered to be achieved by chronic inflammation 
and liver cirrhosis (Di Bisceglie, et al., 2000).
World Health Organization estimates that 
worldwide 170 million people - 3% of world popu-
lation, are infected with chronic hepatitis C (WHO, 
2002). Antibodies for hepatitis C were detected in 
76% of patients suffering from liver cancer in Japan, 
Spain and Italy (Simonetti, et al., 1991). Hepatitis 
C is becoming a leading risk factor for liver cancer 
which is rising in the past 20 years in Western Eu-
rope, United States and Canada (Yu, et al., 2000).
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Chemical carcinogens 
A variety of chemical substances ranging from 
food products, detergents, cosmetics and pharma-
ceuticals, heavy metals, pesticides, polychlorinat-
ed biphenyls, and many others have the potential 
power of carcinogenesis, and many of them have 
hepatotoxic effects (Leong, Leong, 2005). 
Alcohol drinking has been documented as the 
risk factor for HCC. It is believed that alcohol it-
self has no carcinogenic effect on the liver, how-
ever, together with other factors such as hepatitis, 
hepatotoxins and nicotine can contribute in the 
development of liver cancer and its chronic use 
complicates this malignancy (Naccarato, Farina-
ti, 1991).
Physical carcinogens 
Different types of radiation may cause malignant 
alteration. Especially α, β and γ radiation which, 
among other things, may bolster the development 
of liver cancer (Leong, Leong, 2005). Thorotrast 
(radioactive thorium dioxide used as an X-ray con-
trast medium) exposure increases the risk of HCC. 
Studies in Japan and Germany have demonstrated 
association between thorotrast exposure and risk 
for development of liver cancer (Van Kaick, et al., 
1986; Kato, Kido, 1987).
Biological carcinogens 
Mycotoxins - Aflatoxins and Fumonisins (FB)
Filamentous fungi Aspergillus flavus and Aspergil-
lus parasitans are widespread in nature, and grow 
best in regions with tropical and subtropical cli-
mate due to ideal conditions for their development 
which involves mainly high temperature and hu-
midity. They produce toxic and carcinogenic sub-
stances - aflatoxin metabolites that can cause liver 
damage in high doses. Aflatoxins and FB contami-
nate a large fraction of the world’s food, including 
maize, cereals, groundnuts and tree nuts (Wogan, 
1999; Richard, Payne, 2003). 
Microcystins 
The uneven geographical distribution of PLC may 
be due to the presence of MCs - secondary me-
tabolites of cyanobacteria, which have hepatotox-
ic and potentially cancerogenic effects (Kondo, et 
al., 1989). Their most toxic structural variant is 
microcystin-LR, produced by the cyanobacteria 
mostly from the genera Microcystis, Anabaena and 
Planktothrix. 
Cyanotoxins may be connected to the mem-
brane or located free within the cell. They can 
be released during the life of the cell and after its 
death, by passive leakage of cell content when cy-
anotoxins are released in large quantities into the 
environment (Fitzgerald, 2001). This phenome-
non is particularly emphasized during the “water 
bloom”- a massive development of cyanobacteria 
in the aquatic ecosystems, with high concentra-
tions of toxins in drinking or recreational water 
which can be potentially dangerous to human 
health (Falconer, 2007).
The main target organ of cyanotoxins is liv-
er, where MCs can lead to its damage - major he-
patic necrosis and hemorrhage, due to destruc-
tion of the cytoskeleton and inhibition of protein 
phosphatase. Chronic intake of these toxins has 
a promotional role in the growth of liver tumors 
but its carcinogenic effect in humans has not yet 
been proven (Svirčev, 2001; Svirčev, et al., 2009). 
However, MC-LR was studied in experimen-
tal animals and it was shown that it causes liv-
er tumor promotion (Nishiwaki-Matsushima, et 
al.,1992).
Exposure to MCs results in morphological and 
functional changes in hepatocytes, leading to ne-
crosis and apoptosis or cell proliferation, which 
depends on the dose and duration of exposure to 
toxins (Svirčev, et al., 2010). It can be assumed that 
the MC can be an initiator (Ito, et al., 1997; Yu, et 
al., 2001; Žegura, et al., 2008) and promoter (Hu, 
et al., 2002; Nishiwaki-Matsushima, et al., 1992) of 
carcinogenesis, but to determine what is the ex-
act effect on gene regulation further investigation 
is required. 
There is a limited number of epidemiological 
studies that have dealt with the issue of MCs in 
surface drinking water regarding the incidence 
of primary liver cancer. Reports of such analysis 
mainly come from China (Yu, 1995; Ueno, et al., 
1996) and Florida (Fleming et al., 2002), where peo-
ple drink water from the water reservoir affected 
with cyanobacterial “bloom”. In recent years, re-
search on the effect of cyanobacterial hepatotox-
ins was carried out in Serbia (Svirčev, et al., 2009).
The aim of this paper was to determine the in-
cidence of PLC in Central Serbia, and to review 
the epidemiology of the main risk factors for this 
malignant disease. For achieving this goal it was 
necessary to examine the following:
•	 the incidence of PLC, liver cirrhosis and chron-
ic HBV and HCV from 2000 until 2006 year 
for the population of Central Serbia and its re-
gions;
•	 to determine whether there is a correlation 
between liver cancer and its main risk factors 
during the examination period;
•	 to determine the existence of other risk factors 
for the occurrence of PLC with special refer-
ence to the blooming of toxic cyanobacteria in 
reservoirs for water supply.
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Methods and data
Databases 
As a source of data on incidence and mortality of 
primary liver cancer in central Serbia for this study 
published material of the Institute of Public Health 
of Serbia “Dr Milan Jovanović Batut”, Belgrade (Can-
cer Registry of Central Serbia, 2000-2006) was used. 
Data on chronic hepatitis B virus (cum delta agent 
and sine delta agent) and hepatitis C is from Cent-
er for Prevention and Control of Infectious Diseases 
(Infectious Diseases in the Republic of Serbia with-
out Kosovo and Metohija from 2000 to 2006). Data 
on mortality of liver cirrhosis in electronic form is 
also obtained from the Institute of Public Health of 
Serbia “Dr Milan Jovanović Batut”. 
Regional divisions of central Serbia 
Serbia is divided into three areas: Vojvodina (7 
regions), Kosovo (5 counties) and central Ser-
bia. Central Serbia includes 18 regions (Rasins-
ki, Zaječarski, Mačvanski, Borski, Podunavski, 
Pčinjski, Moravički, Zlatiborski, Braničevski, Po-
moravski, Beogradski, Jablanički, Raški, Kolubar-
ski, Pirotski, Šumadijski, Niški, Toplički) with an 
estimated 5,408,971 inhabitants in 2006 (Insti-
tute of public health of Serbia, Health statistical 
yearbook of Republic of Serbia 2006).
Statistical analysis 
Numerical data were statistically analyzed using 
ANOVA (analysis of variance), F-test and student 
t-test. The results are given in tables and graphs. 
The correlation coefficient between the primary 
liver carcinoma, cirrhosis mortality and chronic vi-
ral hepatitis B and C was determined and average 
values of four characteristics that were observed 
during the seven year period, since 2000 to 2006 
were used. Statistical analysis was performed us-
ing the software package Statgraphics Centurion 
(Lindsey, 2004; Tepavčević, Lužanin, 2006).
Results 
Primary liver cancer incidence in Serbia
In central Serbia there was a slight increas in inci-
dence of primary liver cancer from 2000 to 2003 
when it reached its highest value of 18.9/100,000. 
Then it started to fall, and the value of the inci-
dence in 2006 was 12.4/100,000. This trend was 
not present in all the regions. Decline was re-
corded in Belgrade, Kolubarski, Šumadijski and 
Pomoravski, but increase in incidence was seen 
in Pirotski, Toplički, Braničevski, Moravički and 
Mačvanski region, while in the remaining regions 
incidence varies. The highest average incidence of 
PLC was found in Nišavski (32.8), Toplički (30.2), 
Pirotski (23.9) and Šumadijski (23.6) region, and 
lowest was in Rasinski (5) (Table 1, Fig. 1).
Cirrhosis
Liver cirrhosis mortality in central Serbia slightly 
fluctuated during the seven years study. Its high-
est rate was 8.3 per 100,000 in 2000, and lowest 
6.2 / 100,000 in 2005. At the region level, there was 
also no regularity in decline or increase of mortal-
Figure 1. The average values of PLC incidence rate from 2000 to 2006 by regions: (0) Central Serbia, (1) 
Rasinski, (2) Zaječarski, (3) Moravički, (4) Zlatiborski, (5) Pčinjski, (6) Jablanički, (7) Borski, (8) Pomoravski, (9) 
Braničevski, (10) Mačvanski, (11) Podunavski, (12) Raški, (13) Beogradski, (14) Kolubarski, (15) Šumadijski, (16) 
Pirotski, (17) Toplički, (18) Nišavski
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ity rates from this chronic liver disease. The high-
est mean values of cirrhosis mortality occured 
in Braničevski (11.6), Pomoravski (11.5) and Bor-
ski (10.7) region, while the lowest were present in 
Zlatiborski (4.9), Kolubarski (5.1) and Podunavski 
(5.4) (Fig. 2). Regions which have a high incidence 
of PLC- Šumadijski, Nišavski Toplički and Pirot-
ski have intermedial mortality rate of liver cirrho-
sis.
Chronic HBV
Chronic HBV in central Serbia is increasing. Its 
incidence in 2000 was 0.4 per 100,000 and in 
2006 2/100,000. Incidence in regions vary. There-
fore, common patterns can not be found. By far 
the highest average values for incidence of chronic 
HBV have regions: Borski (4.7), Zaječarski (3.7) and 
Pomoravski (3.4), while lowest were in Šumadijski 
and Moravički with incidence of 0.5 per 100,000 
(Fig. 3). Regions with a high incidence of PLC (Bor-
ski, Toplički and Pirotski) are among those with 
low average incidence of this infectious disease.
Chronic HCV
Chronic HCV in central Serbia increased signifi-
cantly. Its incidence in 2000 was 0.3 per 100,000, 
and even 6.2 per 100,000 in 2006. And in most 
regions, in the last two to three years, there has 
been a higher incidence of HCV. This trend do not 
follow Zaječarski, Borski and Jablanički region, 
because they had fluctuations in incidence dur-
ing the 7 year period of this study. Highest aver-
age values of the incidence of chronic HCV have 
regions: Borski (6.7), Kolubarski (4.5), Šumadijski 
(4.4) and Mačvanski (4.2), while Pčinjski (0.5), 
Toplički (0.7), Jablanički (0.8) and the Moravički 
(0.8) have the lowest (Fig. 3). Nišavski and Pirots-
ki have a high incidence of PLC but in the case of 
HCV have low incidence rate.
Incidence ratio of PLC, HBV, HCV  
and cirrhosis mortality
From the obtained data on average values of inci-
dence for the PLC, HBV, HCV and liver cirrhosis 
mortality from 2000 to 2006 it can be noted that 
regions such as Šumadijski, Nišavski, Toplički and 
Pirotski, with the highest values of incidence of liv-
er cancer, have a medium values of cirrhosis mortal-
ity and low incidence of viral hepatitis. Based on this, 
we can conclude that in the observed period there 
was no correlation between PLC and these diseas-
es that are considered to represent its most impor-
tant risk factors. Liver cirrhosis mortality is data on 
deaths caused by liver cirrhosis, and they will not de-
velop into liver cancer. If cirrhosis causes liver can-
cer then the curve of cirrhosis mortality should fol-
low the incidence of PLC. However, this is not the 
case in the period from 2000 to 2006 in central Ser-
bia. Chronic HBV and in particular HCV are on the 
rise since 2000 by 2006 in central Serbia. This in-
crease is particularly pronounced since 2004 when 
there has been a decline in incidence of PLC. Thus, 
the correlation between liver cancer and viral dis-
eases in its seven-year period does not exist (Fig. 4).
The figure 5 shows the downward curve of PLC 
incidence from the Nišavski region with the high-
est incidence to the Rasinski with the lowest. Par-
allel to it are curves for liver cirrhosis mortality 
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Figure 2. The average values of chirrhosis mortality rate from 2000 to 2006 by regions: (0) Central Serbia, (1) 
Rasinski, (2) Zaječarski, (3) Moravički, (4) Zlatiborski, (5) Pčinjski, (6) Jablanički, (7) Borski, (8) Pomoravski, (9) 
Braničevski, (10) Mačvanski, (11) Podunavski, (12) Raški, (13) Beogradski, (14) Kolubarski, (15) Šumadijski, (16) 
Pirotski, (17) Toplički, (18) Nišavski 
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and incidence of hepatitis B and C for given re-
gions, which are similar to each other, but do not 
follow the curve of PLC.
Discussion 
The development of PLC is mostly associated with 
cirrhosis and chronic viral hepatitis. Namely, it is 
considered that, in most countries, in 80-90% cas-
es of liver cirrhosis turns into liver cancer. However, 
this can not be clearly inferred from data on the in-
cidence of PLC and liver cirrhosis mortality trends 
in the period from 2000 to 2006 in central Serbia. 
Braničevski, Pomoravski and Borski regions 
with the highest mortality rate of cirrhosis, have 
a medium incidence of liver cancer. Regions with 
low rates of cirrhosis mortality, such as Zlatibor-
ski, Kolubarski and Podunavski, also have me-
dium incidences of PLC. In the Rasinski region 
presence of medium incidence for cirrhosis mor-
tality and low incidence of cancer can lead to the 
assumption that, due to cirrhosis mortality, there 
has not been a rise of cancer. Also, in this re-
gion cirrhosis may be an important risk factor for 
PLC but this can not explain the high incidence 
in Nišavski, Toplički, Pirotski and Šumadijski re-
Figure 3. The average values of HBV and HCV incidence rate from 2000 to 2006 by regions: (0) Central Serbia, (1) 
Rasinski, (2) Zaječarski, (3) Moravički, (4) Zlatiborski, (5) Pčinjski, (6) Jablanički, (7) Borski, (8) Pomoravski, (9) 
Braničevski, (10) Mačvanski, (11) Podunavski, (12) Raški, (13) Beogradski, (14) Kolubarski, (15) Šumadijski, (16) 
Pirotski, (17) Toplički, (18) Nišavski
Figure 4. The ratio of incidence for PLC, cirrhosis mortality, HBV and HCV in central Serbia by year
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gions. The only option that can be offered as an 
explanation for this ambiguities is the presence of 
some other risk factors that act in given regions. 
In addition to liver cirrhosis, the major risk fac-
tors for PLC are considered to be chronic HBV and 
HCV. In the world, including Serbia, there is a grow-
ing trend in the number infected by these virus-
es. Often the higher incidence of PLC in the West-
ern world is associated with an increased number 
of infected by hepatitis B and C. However, in cen-
tral Serbia, there is a rise in the number infected by 
these viruses although PLC is declining. Correlation 
between the PLC and HBV or HCV in the period 
from 2000 to 2006 did not exist. In addition, in re-
gions with high incidence of PLC (Nišavski, Toplički, 
Pirotski and Šumadijski) it was expected to also 
have a high incidence of hepatitis, but this was not 
the case. On the contrary, low incidence value was 
recorded there. Also, in Pomoravski, Zaječarski and 
Borski regions with higher incidence of HBV and 
HCV, low incidences of PLC were noted. 
This may indicate that, despite of these well-
known and generally accepted risk factors, there 
are some others that can largely influence the oc-
currence of liver cancer. Or perhaps it is just a 
matter of time and it is necessary for many years 
to pass in order to find the correlation between 
given diseases. If the first hypothesis is the case, 
then a contributory factor could be microcystin.
 According to recent research on the associa-
tion between PLC with the presence of microcyst-
ins in drinking water in central Serbia (more spe-
cifically related to the water “bloom”), it can be 
said that there is a connection between this risk 
factors and incidence of PLC (Svirčev, et al., 2006, 
2009). Previous studies (Dyukicy et al., 1997; Mat-
avulj et al., 2007; Svirčev, et al., 2007) show that 
since 1980 large number of aquatic ecosystems in 
Serbia are “blooming”. Surface-water reservoirs in 
central Serbia are particularly vulnerable to this, 
where from 20 reservoirs of drinking water 9 have 
a prolonged and extensive cyanobacterial “bloom” 
during the summer months. In contrast, Vojvodi-
na and Kosovo have underground water sources 
and can be considered as a control. 
During the period since 1980 to 1990 the mor-
tality of PLC was lowest in Kosovo (2.7), then in 
Vojvodina (7.6) and then in the regions of cen-
tral Serbia which are not affected by cyanobacte-
rial “blooming” (8.3). In contrast, in the regions 
(Moravički, Šumadijski, Raški, Braničevski, Ra-
sinski, Zaječarski, Nišavski, Toplički and Pirot-
ski) affected by this phenomenon, mortality was 
11.6. So, in the regions with high mortality rates 
there are surface water reservoirs for water sup-
ply that “bloom” and therefore contain cyanotox-
ins (Svirčev, et al., 2009).
In 2000 there was a significant increase in the 
incidence of PLC in central Serbia (16), and this 
trend continued in 2002 (18.8). In contrast, dur-
ing the same period in Vojvodina there was stag-
nation of these values (6.6 and 6.2). In fact, during 
the epidemiological analysis from 2000 to 2002 a 
statistically significant difference between cen-
tral Serbia and the control region Kosovo (4.1) and 
Vojvodina (5.2) was found, as well as parts of cen-
tral Serbia which are not affected by “blooming” of 
water, where incidence of PLC (13.6) was far low-
er than in the three regions - Šumadijski, Nišavski 
and Toplički where it was 34.7. These regions are 
Figure 5. The ratio of average values of the incidence for PLC, HBV, HCV and liver cirrhosis mortality from 2000 
to 2006 by regions: (0) Central Serbia, (1) Rasinski, (2) Zaječarski, (3) Moravički, (4) Zlatiborski, (5) Pčinjski, 
(6) Jablanički, (7) Borski, (8) Pomoravski, (9) Braničevski, (10) Mačvanski, (11) Podunavski, (12) Raški, (13) 
Beogradski, (14) Kolubarski, (15) Šumadijski, (16) Pirotski, (17) Toplički, (18) Nišavski
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the most affected by PLC and receive water from a 
reservoirs affected by blooming of cyanobacteria 
in summer (Bovan, Gruža, Grošnica, Garaši, Pri-
dvorica, Bresnica, Ćelije i Brestovac) (Svirčev, et al., 
2009). The same was obtained for the period since 
2000 by 2006 (Fig. 6). 
Based on these data it can be seen that regions 
of high risk for PLC match those that have water 
reservoirs affected by cyanobacterial “bloom”, so 
the unequal geographic distribution of liver can-
cer in central Serbia could be correlated with the 
quality of drinking water (Svirčev, et al., 2009).
Similar relationships between increased risk 
for PLC and the quality of drinking surface wa-
ter was detected by Fleming and associates (2002) 
in Florida. Also, such analysis were conducted in 
China where some authors (Yu, 1995; Ueno, et al., 
1996) suggest the possibility that hepatotoxins 
from drinking water (from water reservoirs affect-
ed with cyanobacteria) are the trigger for the de-
velopment of a PLC.
However, the prevailing opinion in the litera-
ture is that development of PLC is a result of ex-
posure to other risk factors (Falconer, Hump-
age, 1996; Lian, et al., 2006) such as hepatitis B 
or C, aflatoxins in food or excessive use of alco-
hol (Yu, 1995; Ueno, et al., 1996; McGlynn, et al., 
2001). Studies have also shown that a combination 
of different risk factors, particularly HBV, aflatox-
in and MCs, may be responsible for the endemici-
ty of PLC (Yu, et al., 2001).
Despite the belief that other risk factors cause 
liver cancer, some studies suggest that MC may 
be a potential carcinogen (Ito, et al.,1997; Suzuki, 
et al., 1998; Hu, et al., 2002; Svirčev, et al., 2006, 
2010). IARC (Agency for Research on Cancer) in 
2006 in Lyon did an assessment on cancerogen-
esis of MC-LR. Based on the facts that these tox-
ins, through inhibition of protein phosphatase in 
the liver and hepatocytes of rodents promote tu-
morigenesis (Yoshizawa, et al., 1990), change the 
expression of oncogenes and tumor necrosis fac-
tor α, and thus affect cell division, its survival and 
apoptosis (Ohta, et al., 1994; Sueoka, et al., 1997; 
Chen et al., 2005), it was concluded that the MC-
LR is possible carcinogen to humans. 
Because of this fact, this paper presents a hy-
pothesis that does not suggest that cyanotoxins 
in drinking water are the only and definitive risk 
factor of PLC. It only indicates that cyanotoxins, 
among others, could be a potential risk factors 
that should require more attention in the future. 
Conclusion
PLC in central Serbia in the period from 2000 
to 2006 had an average value of incidence 16.9 
per 100,000, which fits into the European frame-
work. Based on the data from regions of central 
Serbia, it can not be concluded that the main 
risk factors-liver cirrhosis and chronic HBV and 
HCV represent the main and only cause of this 
disease. Very high incidence of PLC in Nišavski, 
Toplički, Pirotski and Šumadijski regions testi-
fy to the fact that it is a multifactorial disease. 
 One of the risk factors of PLC, and therefore the 
reasons for its uneven geographical distribution, 
can be presence of hepatotoxins in drinking wa-
ter. Based on existing data, it was found that the 
high incidence of PLC correlates with the appear-
ance of water “blooms” and the presence of MCs. 
 For more reliable conclusions about contribut-
ers to occurrence of liver cancer, more research 
should be done, because it could give some an-
swers about potential prevention and reme-
dy for this relentless disease that takes between 
250,000 and one million lives annually world-
wide.
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Figure 6. The incidence rates of PLC in central Serbia for 2000-2006 
and reservoirs that were “blooming” in that period (larger/darker 
dots on the map). 
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